The PDQ cancer information summaries are reviewed regularly and updated as new information becomes available. This section describes the latest changes made to this summary as of the date above.

Intervention

Added text to state that the U.S. Food and Drug Administration has reviewed information on the use of erythropoiesis-stimulating agents (ESAs) for chemotherapy-induced anemia in cancer patients and has revised the safety data.

Back to Top

< Previous Section  |  Next Section >